☆ 4.7 Article

Generation of a bank of clinical-grade, HLA-homozygous iPSC lines with high coverage of the Spanish population

STEM CELL RESEARCH & THERAPY (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Editorial Material Cell & Tissue Engineering

An HLA-homozygous haplobank resource to promote safer cell therapies

Glyn Nigel Stacey

Summary: Researchers have successfully established an HLA-homozygous haplobank of iPSCs that can be used for allogeneic transplantation in approximately 40% of the Japanese population. They also discuss the quality and safety considerations for manufacturing these cells.

CELL STEM CELL (2023)

添加到收藏夹

Article Medicine, Research & Experimental

A clinical-grade HLA haplobank of human approximately 40% of the Japanese population

Shinsuke Yoshida et al.

Summary: A clinically applicable iPSC haplobank has been established in Japan, consisting of 27 iPSC lines that match approximately 40% of the Japanese population. These lines have been used in over 10 clinical trials since their release in 2015.

MED (2023)

添加到收藏夹

Review Biochemistry & Molecular Biology

Current status and future directions of clinical applications using iPS cells-focus on Japan

Hiraku Tsujimoto et al.

Summary: This review summarized the remarkable progress in regenerative medicine using iPS cell technologies in recent years, including the establishment of iPS cells, clinical applications, and disease models generated from patient iPS cells. Research has shown the potential of iPS cell technology in treating ophthalmological, neurological, cardiac, hematological, cartilage, and metabolic diseases, providing new insights for the treatment of intractable diseases.

FEBS JOURNAL (2022)

添加到收藏夹

Article Hematology

Dual-antigen targeted off-the-shelf NK cells show durable response and prevent antigen escape in lymphoma and leukemia

Frank Cichocki et al.

BLOOD (2022)

添加到收藏夹

Article Genetics & Heredity

Substantial somatic genomic variation and selection for BCOR mutations in human induced pluripotent stem cells

Foad J. Rouhani et al.

Summary: The study explores human induced pluripotent stem cells derived from different tissues, finding UV-related damage and mutations in skin fibroblast-derived cells, while blood-derived cells show a high prevalence of acquired mutations.

NATURE GENETICS (2022)

添加到收藏夹

Article Cell & Tissue Engineering

Public Cord Blood Banks as a source of starting material for clinical grade HLA-homozygous induced pluripotent stem cells

Belen Alvarez-Palomo et al.

Summary: This article describes the process of generating a CD34+ cell product as a starting material to produce HLA-homozygous iPSC following a cost-effective and clinical grade-compliant procedure, starting from unit selection and donor reconsenting. These CD34+ cells serve as the basis for the Spanish bank of haplolines, aimed to provide cell products for clinical research and therapy.

STEM CELL RESEARCH & THERAPY (2022)

添加到收藏夹

Article Cell & Tissue Engineering

Blood donor biobank and HLA imputation as a resource for HLA homozygous cells for therapeutic and research use

Jonna Clancy et al.

Summary: This study demonstrates that HLA imputation in a reasonably sized blood donor biobank can be used to identify suitable HLA-homozygous blood donors for cell therapy, HLA-typed thrombocytes, and research purposes. The homozygotes are HLA-compatible with a large fraction of the Finnish population. Regular blood donors with a positive attitude towards research donation are a good option for these purposes.

STEM CELL RESEARCH & THERAPY (2022)

添加到收藏夹

Article Cell & Tissue Engineering

Identification and Re-consent of Existing Cord Blood Donors for Creation of Induced Pluripotent Stem Cell Lines for Potential Clinical Applications

Keren M. Abberton et al.

Summary: The goal of this study is to create a bank of clinical-grade iPSC lines derived from cord blood. Regulatory challenges, quality standards, and collaboration with relevant organizations have been addressed. Suitable donors were identified through cord blood bank inventory and sequencing. Ethics and government approvals were obtained, and donor safeguards were considered. The feasibility and utility of using banked cord blood for potential cellular therapies have been confirmed.

STEM CELLS TRANSLATIONAL MEDICINE (2022)

添加到收藏夹

Review Cell & Tissue Engineering

The consequences of recurrent genetic and epigenetic variants in human pluripotent stem cells

Peter W. Andrews et al.

Summary: This study summarizes the genetic and epigenetic changes that human pluripotent stem cells (hPSCs) can acquire during in vitro culture, as well as the methods for detecting these changes and their effects on cell behavior. The study argues that the potential consequences of low-level contamination of cell therapy products with cells bearing oncogenic variants are currently unknown, and highlights the challenges in safety assessment of hPSC-derived cellular therapeutics.

CELL STEM CELL (2022)

添加到收藏夹

Article Cell & Tissue Engineering

Korea National Stem Cell Bank

Jung-Hyun Kim et al.

Summary: The Korea National Stem Cell Bank has been storing pluripotent stem cell lines since 2012, distributing research-grade human embryonic stem cell and induced pluripotent stem cell lines, as well as GMP-compliant homozygous iPSC lines. Quality of the cell lines is ensured through 18 different tests, and genetic stability data is collected for public access.

STEM CELL RESEARCH (2021)

添加到收藏夹

Article Cell & Tissue Engineering

Evaluation of the Spanish population coverage of a prospective HLA haplobank of induced pluripotent stem cells

Belen Alvarez-Palomo et al.

Summary: The background of generating iPSC haplobanks with homogeneous HLA haplotypes for allogeneic transplantation has been proposed as a cost-effective method. Initiatives have been made globally to create national and international iPSC haplobanks matching a significant portion of the population. This study in Spain demonstrates the feasibility of using cord blood units to establish an iPSC haplobank covering a substantial percentage of the population for future therapeutic strategies.

STEM CELL RESEARCH & THERAPY (2021)

添加到收藏夹

Article Cell & Tissue Engineering

GMP Banking of Human Pluripotent Stem Cells: A US and UK perspective

Elsa Abranches et al.

STEM CELL RESEARCH (2020)

添加到收藏夹

Article Cell & Tissue Engineering

Development and implementation of large-scale quality control for the European bank for induced Pluripotent Stem Cells

Orla O'Shea et al.

STEM CELL RESEARCH (2020)

添加到收藏夹

Article Cell & Tissue Engineering

A Manually Curated Database on Clinical Studies Involving Cell Products Derived from Human Pluripotent Stem Cells

Sabine Kobold et al.

STEM CELL REPORTS (2020)

添加到收藏夹

Review Cell & Tissue Engineering

Haplobanking induced pluripotent stem cells for clinical use

Stephen Sullivan et al.

STEM CELL RESEARCH (2020)

添加到收藏夹

Article Cell & Tissue Engineering

GMP-compatible manufacturing of three iPS cell lines from human peripheral blood

Alexandra Haase et al.

STEM CELL RESEARCH (2019)

添加到收藏夹

Review Medicine, General & Internal

Adapting Cord Blood Collection and Banking Standard Operating Procedures for HLA-Homozygous Induced Pluripotent Stem Cells Production and Banking for Clinical Application

Belen Alvarez-Palomo et al.

JOURNAL OF CLINICAL MEDICINE (2019)

添加到收藏夹

Review Cell & Tissue Engineering

Concise Review: Towards the Clinical Translation of Induced Pluripotent Stem Cell-Derived Blood Cells-Ready for Take-Off

Kathrin Haake et al.

STEM CELLS TRANSLATIONAL MEDICINE (2019)

添加到收藏夹

Article Cell & Tissue Engineering

Recent progress of national banking project on homozygous HLA-typed induced pluripotent stem cells in South Korea

Yeri Alice Rim et al.

JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE (2018)

添加到收藏夹

Article Cell & Tissue Engineering

Repurposing the Cord Blood Bank for Haplobanking of HLA-Homozygous iPSCs and Their Usefulness to Multiple Populations

Suji Lee et al.

STEM CELLS (2018)

添加到收藏夹

Article Cell & Tissue Engineering

Quality control guidelines for clinical-grade human induced pluripotent stem cell lines

Stephen Sullivan et al.

REGENERATIVE MEDICINE (2018)

添加到收藏夹

Article Biotechnology & Applied Microbiology

Influence of donor age on induced pluripotent stem cells

Valentina Lo Sardo et al.

NATURE BIOTECHNOLOGY (2017)

添加到收藏夹

Article Medicine, General & Internal

Autologous Induced Stem-Cell-Derived Retinal Cells for Macular Degeneration

M. Mandai et al.

NEW ENGLAND JOURNAL OF MEDICINE (2017)

添加到收藏夹

Article Cell & Tissue Engineering

Development and production of good manufacturing practice grade human embryonic stem cell lines as source material for clinical application

P. A. De Sousa et al.

STEM CELL RESEARCH (2016)

添加到收藏夹

Article Cell & Tissue Engineering

Points to consider in the development of seed stocks of pluripotent stem cells for clinical applications: International Stem Cell Banking Initiative (ISCBI)

P. W. Andrews et al.

REGENERATIVE MEDICINE (2015)

添加到收藏夹

Article Cell & Tissue Engineering

cGMP-Manufactured Human Induced Pluripotent Stem Cells Are Available for Pre-clinical and Clinical Applications

Behnam Ahmadian Baghbaderani et al.

STEM CELL REPORTS (2015)

添加到收藏夹

Article Multidisciplinary Sciences

Rapid and Efficient Conversion of Integration-Free Human Induced Pluripotent Stem Cells to GMP-Grade Culture Conditions

Jens Durruthy-Durruthy et al.

PLOS ONE (2014)

添加到收藏夹

Editorial Material Cell & Tissue Engineering

Toward the Development of a Global Induced Pluripotent Stem Cell Library

Marc Turner et al.

CELL STEM CELL (2013)

添加到收藏夹

Article Biochemical Research Methods

Characterization of pluripotent stem cells

Merce Marti et al.

NATURE PROTOCOLS (2013)

添加到收藏夹

Article Multidisciplinary Sciences

Few Single Nucleotide Variations in Exomes of Human Cord Blood Induced Pluripotent Stem Cells

Rui-Jun Su et al.

PLOS ONE (2013)

添加到收藏夹

Editorial Material Cardiac & Cardiovascular Systems

Immunogenicity of Induced Pluripotent Stem Cells

Keisuke Okita et al.

CIRCULATION RESEARCH (2011)

添加到收藏夹

Article Cell & Tissue Engineering

Induced pluripotent stem cells from GMP-grade hematopoietic progenitor cells and mononuclear myeloid cells

Seiga Ohmine et al.

STEM CELL RESEARCH & THERAPY (2011)

添加到收藏夹

Article Cell & Tissue Engineering

Generation of Induced Pluripotent Stem Cells from Human Cord Blood Using OCT4 and SOX2

Alessandra Giorgetti et al.

CELL STEM CELL (2009)

添加到收藏夹

Letter Biotechnology & Applied Microbiology

HLA-haplotype banking and iPS cells

Norio Nakatsuji et al.

NATURE BIOTECHNOLOGY (2008)

添加到收藏夹

Article Multidisciplinary Sciences

Induced pluripotent stem cell lines derived from human somatic cells

Junying Yu et al.

SCIENCE (2007)

添加到收藏夹

Article Biochemical Research Methods

Induction of pluripotent stem cells from fibroblast cultures

Kazutoshi Takahashi et al.

NATURE PROTOCOLS (2007)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.